A — Cardiovascular & Cerebrovascular

(6R,10S)-10-Amino-1-(difluoromethyl)-1,4,7,8,9,10-hexahydro-6-methyl-11,15-metheno-15H-pyrazolo[4,3-b][1,7]diazacyclotetradecin-5(6H)-one

(6R,10S)-10-氨基-1-(二氟甲基)-1,4,7,8,9,10-六氢-6-甲基-11,15-甲基-15H-吡唑并[4,3-b][1,7]二氮杂环四烯-5(6H)-酮

Product Code: A-26

Milvexian(BMS-986177)

Interested in this product?

对此产品感兴趣?

We respond to every inquiry within 24 hours.

Specification

Product Code A-26
CAS No. 1802431-24-8
Chemical Name (EN) (6R,10S)-10-Amino-1-(difluoromethyl)-1,4,7,8,9,10-hexahydro-6-methyl-11,15-metheno-15H-pyrazolo[4,3-b][1,7]diazacyclotetradecin-5(6H)-one
化学名称 (中文) (6R,10S)-10-氨基-1-(二氟甲基)-1,4,7,8,9,10-六氢-6-甲基-11,15-甲基-15H-吡唑并[4,3-b][1,7]二氮杂环四烯-5(6H)-酮
Molecular Formula C₁₆H₁₉F₂N₅O
Molecular Weight (g/mol) 335.35
IUPAC Name (9R,13S)-13-amino-3-(difluoromethyl)-9-methyl-3,4,7,15-tetrazatricyclo[12.3.1.02,6]octadeca-1(18),2(6),4,14,16-pentaen-8-one
Canonical SMILES C[C@@H]1CCC[C@@H](C2=NC=CC(=C2)C3=C(C=NN3C(F)F)NC1=O)N
InChI Key SJFDPTNYLWIEKA-KOLCDFICSA-N
PubChem CID 118277795
Chiral Configuration
ee Requirement
Terminal API Milvexian(BMS-986177)
Therapeutic Area
Application Notes
Category A — Cardiovascular & Cerebrovascular
(6R,10S)-10-Amino-1-(difluoromethyl)-1,4,7,8,9,10-hexahydro-6-methyl-11,15-metheno-15H-pyrazolo[4,3-b][1,7]diazacyclotetradecin-5(6H)-one 2D structure

2D/3D structure via PubChem

Related Products

A-01

5,6-Dihydro-3-(4-morpholinyl)-1-[4-(2-oxo-1-piperidinyl)phenyl]-2(1H)-pyridinone

5,6-二氢-3-(4-吗啉基)-1-[4-(2-氧代-1-哌啶基)苯基]-2(1H)-吡啶酮

CAS No. 545445-44-1

C₂₀H₂₅N₃O₃

A-02

Ethyl (2Z)-chloro[(4-Methoxyphenyl)hydrazono]ethanoate

(2Z)-氯代[(4-甲氧基苯基)亚肼基]乙酸乙酯

CAS No. 473927-63-8

C₁₁H₁₃ClN₂O₃

A-03

(4R,6R)-tert-Butyl-6-cyanomethyl-2,2-dimethyl-1,3-dioxane-4-acetate

(4R,6R)-叔丁基-6-氰甲基-2,2-二甲基-1,3-二氧六环-4-乙酸酯

CAS No. 125971-94-0

C₁₄H₂₃NO₄

A-04

(R)-3-cyclopentyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)propanenitrile

(R)-3-环戊基-3-(4-(4,4,5,5-四甲基-1,3,2-二氧杂硼硼烷-2-基)-1H-吡唑-1-基)丙腈

CAS No. 1146629-84-6

C₁₇H₂₆BN₃O₂

Interested in A-26?

We respond to every inquiry within 24 hours.

Request a Quote →